Information Letter on Zofran® (ondansetron) and generic medicinal products: Risk of QTc prolongation
2013.07.18
Active substance: ondansetron
This communication contains updated information regarding intravenous use of ondansetron for prevention and treatment of chemotherapy-induced nausea, retching and vomiting (CINV), as well as new recommendations for repeated administration and for dosing in the elderly.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN